Dysarthria News and Research

RSS
Neurological complications of the SARS-CoV-2 vaccine

Neurological complications of the SARS-CoV-2 vaccine

Potential link between SARS-CoV-2 infection and secondary occurrence of anti-NMDAR encephalitis

Potential link between SARS-CoV-2 infection and secondary occurrence of anti-NMDAR encephalitis

Study uncovers rare genetic syndrome caused by mutations in gene SATB1

Study uncovers rare genetic syndrome caused by mutations in gene SATB1

Chaperone-mediated autophagy could be a new therapeutic target for spinocerebellar ataxia

Chaperone-mediated autophagy could be a new therapeutic target for spinocerebellar ataxia

Hereditary spastic paraplegia characteristics unveiled

Hereditary spastic paraplegia characteristics unveiled

FDA accepts Allergan's resubmission of BOTOX sBLA for treatment of adults with upper limb spasticity

FDA accepts Allergan's resubmission of BOTOX sBLA for treatment of adults with upper limb spasticity

Study explores prevalence of chronic brain damage in retired NFL players

Study explores prevalence of chronic brain damage in retired NFL players

Communication for people with impaired speech: an interview with Professor Mark Hawley, Professor of Health Services Research, Director of CATCH and lead researcher for VIVOCA

Communication for people with impaired speech: an interview with Professor Mark Hawley, Professor of Health Services Research, Director of CATCH and lead researcher for VIVOCA

Loyola University neuropsychologist find little evidence that chronic traumatic encephalopathy actually exists

Loyola University neuropsychologist find little evidence that chronic traumatic encephalopathy actually exists

Deep-brain stimulation effects sustained in dystonia

Deep-brain stimulation effects sustained in dystonia

Eisai receives FDA approval for Fycompa to treat partial onset seizures

Eisai receives FDA approval for Fycompa to treat partial onset seizures

Poststroke speech therapy ‘should be reorganized’

Poststroke speech therapy ‘should be reorganized’

Poststroke speech therapy ‘should be reorganized’

Poststroke speech therapy ‘should be reorganized’

DBS safe and effective for patients with advanced Parkinson's

DBS safe and effective for patients with advanced Parkinson's

FDA approves Valeant's Potiga Tablets for treatment of partial-onset seizures

FDA approves Valeant's Potiga Tablets for treatment of partial-onset seizures

Seroquel XR supplemental NDA recommended for approval

Seroquel XR supplemental NDA recommended for approval

Speech and language disorders can be assessed over the internet

Speech and language disorders can be assessed over the internet

Stroke severity is the predominant predictor of discharge destination

Stroke severity is the predominant predictor of discharge destination